Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer
Open Access
- 12 February 2018
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2018 (2)
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy of PERT for the treatment of steatorrhoea in people with pancreatic cancer by accessing whether it: reduces the severity and duration of common symptoms, including fatty (greasy or oily appearance and residue), foul-smelling, pale-coloured, and heavy stools (bulky and difficult-to-flush), which are usually associated with weight loss and nutritional deficiencies as a result of fat malabsorption and the concomitant malabsorption of amino acids and vitamins, and abdominal pain or cramps (Cheifetz 2011; Kasper 2015); is an acceptable treatment, as assessed by the number of side effects/adverse events, study dropout rates, and participant satisfaction levels; has an impact on chemotherapy adherence; has an impact on postoperative outcomes.Keywords
This publication has 43 references indexed in Scilit:
- Randomised clinical trial: the efficacy and safety of pancreatin enteric‐coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis ‐ a double‐blind, placebo‐controlled studyAlimentary Pharmacology & Therapeutics, 2012
- Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiencyCore Evidence, 2012
- Enzyme replacement therapy for pancreatic insufficiency: present and futureClinical and Experimental Gastroenterology, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Pancreatic CancerNew England Journal of Medicine, 2010
- Pancreatic CancerAnnual Review of Pathology: Mechanisms of Disease, 2008
- Human pancreatic exocrine response to nutrients in health and diseaseGut, 2005
- Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover studyAlimentary Pharmacology & Therapeutics, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Cancer of the stomach and pancreasBMJ, 2001